Philips Trims Losses, Stops Selling Sleep Devices in US

Philips, a leading healthcare technology company, has recently announced its decision to stop selling sleep devices in the United States. This move comes as part of the company’s efforts to trim losses and focus on its core business areas.

Background

Philips has been facing challenges in its sleep and respiratory care business, which has been impacted by regulatory compliance requirements and supply chain constraints. The company has been working closely with regulatory authorities to address these issues and ensure the safety and effectiveness of its products.

Impact on Customers

While the decision to stop selling sleep devices in the US may come as a disappointment to some customers, Philips is committed to providing support and solutions to those who already own their sleep devices. The company will continue to offer repair and replacement services for affected products.

Focus on Core Business Areas

By discontinuing the sale of sleep devices in the US, Philips aims to redirect its resources and efforts towards its core business areas, such as personal health, diagnosis, treatment, and connected care. This strategic move will enable the company to better serve its customers and drive growth in these key sectors.

Future Plans

Philips remains committed to innovation and plans to invest in research and development to bring new and improved products to the market. The company will continue to work closely with regulatory authorities to ensure compliance and maintain the highest standards of quality and safety.

Conclusion

Philips’ decision to stop selling sleep devices in the US is a strategic move aimed at trimming losses and focusing on its core business areas. While this may impact some customers, the company remains committed to providing support and solutions to existing device owners. Philips will continue to innovate and invest in research and development to bring new and improved products to the market.